Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
about
Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohortFrailty Change and Major Osteoporotic Fracture in the Elderly: Data from the Global Longitudinal Study of Osteoporosis in Women 3-Year Hamilton Cohort.Concern and risk perception: effects on osteoprotective behaviour.Reasons for not initiating osteoporosis therapy among a managed care population.Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.Gastrointestinal events and association with initiation of treatment for osteoporosis.Development of a cloud-based application for the Fracture Liaison Service model of care.Association of gastrointestinal events and osteoporosis treatment initiation in newly diagnosed osteoporotic Israeli women.Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Management of osteoporosis of the oldest old.Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009.
P2860
Q30828154-15E74FCA-EAC6-4E50-A1FF-F07F71548B76Q31019551-B689C28E-8746-4A7B-91A0-F5D40B091C81Q34234269-A6ADE51F-6965-4EBE-88D2-5788091C4387Q35781017-FA7D1EBF-A61D-4226-9CF6-174A66A44A46Q36265141-AD42CEAE-A1CD-40ED-A29F-8B37CE94D93CQ36332223-D9DA896A-3094-4860-9986-7386EBDFBBE4Q36541709-FB12C386-3CB6-466F-BE88-628A16A91F88Q37295877-BFD87493-DA32-4BB6-BC44-AB0A73B7E5D0Q38206066-8592B2B1-248D-43BC-A531-9F95C9C74B1DQ38229503-C36A0C6B-73D8-428F-9911-67C57AC4B523Q41109001-4245CD5D-4EC9-4162-A1F6-8225B0510B91Q47136618-C09C5185-C43C-4DFD-81A8-5259375C61DAQ48287835-8052B3B1-E449-4525-AC04-CA9C1A433680
P2860
Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@ast
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@en
type
label
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@ast
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@en
prefLabel
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@ast
Characteristics associated wit ...... is in Women (GLOW) USA cohort.
@en
P2093
P2860
P1433
P1476
Characteristics associated wit ...... sis in Women (GLOW) USA cohort
@en
P2093
Christian Roux
Ethel S Siris
Frederick A Anderson
Frederick H Hooven
GLOW Investigators
Johannes Pfeilschifter
Jonathan D Adachi
Julie Flahive
Juliet E Compston
Nelson B Watts
P2860
P304
P356
10.1016/J.BONE.2012.08.130
P577
2012-09-03T00:00:00Z